PJT

In the past six months (April-October 2026), PJT Partners' stock experienced mixed impacts. In April 2026, the company reported record first-quarter results with revenues up 29% and GAAP diluted EPS up 11%, alongside an $800 million share repurchase authorization, leading to analyst upgrades from Goldman Sachs and Keefe, Bruyette & Woods. July 2026 saw continued strong performance with record second-quarter and six-month results, including Q2 revenues up 20% and GAAP pretax income up 33%. However, by October 2026, the stock faced pressure due to analyst downgrades and price target cuts from firms like Keefe, Bruyette & Woods, UBS, and Goldman Sachs, citing slower large-cap M&A growth. This resulted in a stock price decline of approximately 25% over the past month and 13% over the past three months, exacerbated by broader market concerns such as higher Treasury yields, elevated oil prices, and Federal Reserve tightening worries.